SCHEMBL7028632

SCHEMBL7028632

Cc1ccccc1NC1c2cccc(Cl)c2C(=O)c2cccc(Cl)c21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PBRM1 Q86U86 7/20 0.41
FABP3 P05413 1/20 0.36
FABP4 P15090 1/20 0.36
ALDH1A1 P00352 4/20 0.35
MAPT P10636 3/20 0.35
NPSR1 Q6W5P4 2/20 0.35
EGFR P00533 1/20 0.35
PABPC1 P11940 1/20 0.35
MAPK1 P28482 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CYP1A1 P04798 1/20 0.35
CYP1A2 P05177 1/20 0.35
ALOX15 P16050 1/20 0.35
KDM4E B2RXH2 1/20 0.33
GAA P10253 1/20 0.33
P2RY2 P41231 1/20 0.33
P2RY4 P51582 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20902858 0.69 HTR7 (0.43) PBRM1ALDH1A1L3MBTL1MAOAADORA2A
SCHEMBL6904744 0.69 ADORA2A (0.41) PBRM1ALDH1A1MAPTNPSR1MAPK1
SCHEMBL12105727 0.66 CYP1A1 (0.50) ALDH1A1MAPK1RAB9ASMN1; SMN2L3MBTL1
SCHEMBL29280562 0.66 ALDH1A1 (0.38) ALDH1A1MAPTNPSR1MAPK1RAB9A
SCHEMBL9122030 0.66 ADORA2A (0.43) PBRM1ALDH1A1MAPTMAPK1SMN1; SMN2
SCHEMBL11481819 0.64 ADORA2A (0.39) PBRM1ALDH1A1MAPTTDP1KDM4E
SCHEMBL7030240 0.64 ALDH1A1 (0.34) PBRM1ALDH1A1MAPTKDM4EADORA2A
SCHEMBL7029698 0.63 ALDH1A1 (0.33) PBRM1ALDH1A1MAPTNPSR1RAB9A
SCHEMBL11809699 0.63 RAB9A (0.46) PBRM1MAPTMAPK1RAB9ASMN1; SMN2
SCHEMBL6905334 0.63 CACNB4 (0.41) PBRM1ALDH1A1NPSR1MAPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6596774-B1 For their ability to inhibit the growth of human oral epidermoid carcinoma cells, human cervical carcinoma cells and Chinese hamster ovary cells NATIONAL SCIENCE COUNCIL OF R.O.C. (TW) 2003-07-22 US disclosed
US-20030135060-A1 Synthesis, lipid peroxidation and cytotoxic evaluation of 10-substituted 1,5-dichloro-9(10H)-anthracenone derivatives NATIONAL SCIENCE COUNCIL OF R.O.C. (TW) 2003-07-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030135060-A1 Synthesis, lipid peroxidation and cytotoxic evaluation of 10-substituted 1,5-dichloro-9(10H)-anthracenone derivatives GPX4, GPX1, AGK PBRM1 2478/4885FABP3 2924/4885FABP4 1203/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.